Home » Topics » Regulatory » Patents

Patents
RSS

Bayer presents Pim kinase inhibitors

Oct. 10, 2017

New endonucleases inhibitors presented by Biotech Innovations

Oct. 9, 2017

University of Michigan and Kura Oncology patent menin-MLL interaction inhibitors

Oct. 9, 2017

Shenzhen Targetrx Biotechnology identifies HBV and HIV compounds

Oct. 9, 2017

Immune Sensor and collaborator divulge new hSTING agonists

Oct. 9, 2017

Shanghai Institute Materia Medica patents IDH1 inhibitors

Oct. 9, 2017

AstraZeneca identifies new serine-protein kinase ATM inhibitors

Oct. 6, 2017

Novel oligopeptides created at Guangzhou Nuowei Biotechnology

Oct. 6, 2017

GlaxoSmithKline identifies novel integrin alphavbeta6 receptor antagonists

Oct. 6, 2017

The University of California, Oakland presents novel apoptosis inducers and splicing modulators

Oct. 6, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...